1. Home
  2. PAX vs MPLT Comparison

PAX vs MPLT Comparison

Compare PAX & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

SELL

Current Price

$11.49

Market Cap

1.8B

Sector

Finance

ML Signal

SELL

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$7.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAX
MPLT
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
PAX
MPLT
Price
$11.49
$7.78
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
$15.00
★ $26.54
AVG Volume (30 Days)
★ 1.1M
420.3K
Earning Date
11-03-2026
12-03-2026
Dividend Yield
★ 5.59%
N/A
EPS Growth
N/A
★ 82.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.76
N/A
Revenue Next Year
$10.10
N/A
P/E Ratio
$25.65
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.89
$7.85
52 Week High
$17.80
$40.43

Technical Indicators

Market Signals
Indicator
PAX
MPLT
Relative Strength Index (RSI) 61.63 22.05
Support Level $11.04 N/A
Resistance Level $11.62 $20.46
Average True Range (ATR) 0.28 0.58
MACD 0.17 -0.04
Stochastic Oscillator 79.80 11.14

Price Performance

Historical Comparison
PAX
MPLT

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: